Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and Carcinoma 256, Walker

n-(2-hydroxypropyl)methacrylamide has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allmeroth, M; Buchholz, HG; Gündel, D; Koynov, K; Moderegger, D; Mohr, K; Rösch, F; Thews, O; Zentel, R1

Other Studies

1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Carcinoma 256, Walker

ArticleYear
HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution.
    Biomacromolecules, 2013, Sep-09, Volume: 14, Issue:9

    Topics: Animals; Carcinoma 256, Walker; Male; Methacrylates; Nanoparticles; Neoplasm Transplantation; Particle Size; Polymethacrylic Acids; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Whole Body Imaging

2013